Yahoo Web Search

Zacks via Yahoo

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

9 hours ago

Morningstar

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Bio-Path Holdings, Inc., (Nasdaq: BPTH) (the “Company” or “Bio-Path”), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle ...

7 hours ago

Zacks via Yahoo

Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition

3 days ago

ETF DAILY NEWS

Bio-Techne (NASDAQ:TECH) Price Target Cut to $82.00 by Analysts at Deutsche Bank Aktiengesellschaft

Bio-Techne (NASDAQ:TECH – Free Report) had its target price trimmed by Deutsche Bank Aktiengesellschaft from $85.00 to $82.00 in a research report sent to investors on Thursday ...

16 hours ago

Zacks via Yahoo

Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?

1 day ago

ETF DAILY NEWS

Bio-Rad Laboratories, Inc. Forecasted to Earn Q1 2025 Earnings of $2.39 Per Share (NYSE:BIO)

Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) – Investment analysts at Zacks Research raised their Q1 2025 earnings per share (EPS) estimates for ...

20 hours ago

ETF DAILY NEWS

Bio-Path’s (BPTH) “Buy” Rating Reaffirmed at Roth Mkm

Roth Mkm reissued their buy rating on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research note published on Thursday, Benzinga reports. Roth Mkm currently has a $40.00 ...

16 hours ago

Fandom

Major Bio-mechanoid

1 day ago

WATE 6 Knoxville

bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUE

The Gross Law Firm issues the following notice to shareholders of bluebird bio, Inc. (NASDAQ: BLUE). Shareholders who purchased shares of BLUE during the class period listed ...

13 hours ago

ETF DAILY NEWS

Brokerages Set bluebird bio, Inc. (NASDAQ:BLUE) Price Target at $5.87

The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $5.87. Wedbush reduced their target price on bluebird bio from $1.72 ...

21 hours ago